Detecting Oligomeric Beta-Amyloid for the Diagnosis of Alzheimer's Disease
abstract: Alzheimer's disease (AD) is the leading neurodegenerative disease, affecting roughly 8% of people 65 years of age or older. There exists an imperative need to develop a non-invasive test for the earlier detection of AD. The use of biomarkers is a promising option that examines the tox...
Other Authors: | |
---|---|
Format: | Dissertation |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/2286/R.I.17777 |